This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chesebro, B Articles by Perryman, S Search for Related Content PubMed PubMed Citation Articles by Chesebro, B Articles by Perryman, S

 Previous Article  |  Next Article 

J Virol. 1992 November; 66(11): 6547-6554

Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism.

Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, Hamilton, Montana 59840.

ABSTRACT

Previous experiments indicate that the V3 hypervariable region of the human immunodeficiency virus (HIV) envelope protein influences cell tropism of infection; however, so far no consistent V3 sequence can account for macrophage or T-cell tropism. In these experiments, we studied infectious recombinant HIV clones constructed by using V3 region sequences of HIV isolates from 16 patients to search for sequences associated with cell tropism. Remarkable homology was seen among V3 sequences from macrophage-tropic clones from different patients, and a consensus V3 region sequence for patient-derived macrophage-tropic viruses was identified. In contrast, V3 sequences of T-cell-tropic clones from different patients were highly heterogeneous, and the results suggested that sequence diversity leading to T-cell tropism might be generated independently in each patient. Site-specific mutations identified amino acids at several positions on each side of the GPGR motif at the tip of the V3 loop as important determinants of tropism for T cells and macrophages. However, a wide variety of mutant V3 sequences induced macrophage tropism, as detected in vitro. Therefore, the homogeneity of macrophage-tropic patient isolates appeared to be the result of selection based on a biological advantage in vivo.

This article has been cited by other articles:

• Usami, Y., Popov, S., Popova, E., Gottlinger, H. G. (2008). Efficient and Specific Rescue of Human Immunodeficiency Virus Type 1 Budding Defects by a Nedd4-Like Ubiquitin Ligase. J. Virol. 82: 4898-4907 [Abstract] [Full Text]  
• Ajamian, L., Abrahamyan, L., Milev, M., Ivanov, P. V., Kulozik, A. E., Gehring, N. H., Mouland, A. J. (2008). Unexpected roles for UPF1 in HIV-1 RNA metabolism and translation. RNA 14: 914-927 [Abstract] [Full Text]  
• Popov, S., Popova, E., Inoue, M., Gottlinger, H. G. (2008). Human Immunodeficiency Virus Type 1 Gag Engages the Bro1 Domain of ALIX/AIP1 through the Nucleocapsid. J. Virol. 82: 1389-1398 [Abstract] [Full Text]  
• Jager, S., Gottwein, E., Krausslich, H.-G. (2007). Ubiquitination of Human Immunodeficiency Virus Type 1 Gag Is Highly Dependent on Gag Membrane Association. J. Virol. 81: 9193-9201 [Abstract] [Full Text]  
• Doehle, B. P., Bogerd, H. P., Wiegand, H. L., Jouvenet, N., Bieniasz, P. D., Hunter, E., Cullen, B. R. (2006). The Betaretrovirus Mason-Pfizer Monkey Virus Selectively Excludes Simian APOBEC3G from Virion Particles. J. Virol. 80: 12102-12108 [Abstract] [Full Text]  
• Goodenow, M. M., Collman, R. G. (2006). HIV-1 coreceptor preference is distinct from target cell tropism: a dual-parameter nomenclature to define viral phenotypes. J. Leukoc. Biol. 80: 965-972 [Abstract] [Full Text]  
• McCrossan, M., Marsden, M., Carnie, F. W., Minnis, S., Hansoti, B., Anthony, I. C., Brettle, R. P., Bell, J. E., Simmonds, P. (2006). An immune control model for viral replication in the CNS during presymptomatic HIV infection. Brain 129: 503-516 [Abstract] [Full Text]  
• Gondois-Rey, F., Biancotto, A., Fernandez, M. A., Bettendroffer, L., Blazkova, J., Trejbalova, K., Pion, M., Hirsch, I. (2006). R5 Variants of Human Immunodeficiency Virus Type 1 Preferentially Infect CD62L- CD4+ T Cells and Are Potentially Resistant to Nucleoside Reverse Transcriptase Inhibitors. J. Virol. 80: 854-865 [Abstract] [Full Text]  
• Yusa, K., Maeda, Y., Fujioka, A., Monde, K., Harada, S. (2005). Isolation of TAK-779-resistant HIV-1 from an R5 HIV-1 GP120 V3 Loop Library. J. Biol. Chem. 280: 30083-30090 [Abstract] [Full Text]  
• Wapling, J., Moore, K. L., Sonza, S., Mak, J., Tachedjian, G. (2005). Mutations That Abrogate Human Immunodeficiency Virus Type 1 Reverse Transcriptase Dimerization Affect Maturation of the Reverse Transcriptase Heterodimer. J. Virol. 79: 10247-10257 [Abstract] [Full Text]  
• Doehle, B. P., Schafer, A., Wiegand, H. L., Bogerd, H. P., Cullen, B. R. (2005). Differential Sensitivity of Murine Leukemia Virus to APOBEC3-Mediated Inhibition Is Governed by Virion Exclusion. J. Virol. 79: 8201-8207 [Abstract] [Full Text]  
• Pyeon, D., Lambert, P. F., Ahlquist, P. (2005). Production of infectious human papillomavirus independently of viral replication and epithelial cell differentiation. Proc. Natl. Acad. Sci. USA 102: 9311-9316 [Abstract] [Full Text]  
• Walter, B. L., Wehrly, K., Swanstrom, R., Platt, E., Kabat, D., Chesebro, B. (2005). Role of Low CD4 Levels in the Influence of Human Immunodeficiency Virus Type 1 Envelope V1 and V2 Regions on Entry and Spread in Macrophages. J. Virol. 79: 4828-4837 [Abstract] [Full Text]  
• Platt, E. J., Shea, D. M., Rose, P. P., Kabat, D. (2005). Variants of Human Immunodeficiency Virus Type 1 That Efficiently Use CCR5 Lacking the Tyrosine-Sulfated Amino Terminus Have Adaptive Mutations in gp120, Including Loss of a Functional N-Glycan. J. Virol. 79: 4357-4368 [Abstract] [Full Text]  
• Evans, D. T., Bricker, J. E., Desrosiers, R. C. (2004). A Novel Approach for Producing Lentiviruses That Are Limited to a Single Cycle of Infection. J. Virol. 78: 11715-11725 [Abstract] [Full Text]  
• Luo, K., Liu, B., Xiao, Z., Yu, Y., Yu, X., Gorelick, R., Yu, X.-F. (2004). Amino-Terminal Region of the Human Immunodeficiency Virus Type 1 Nucleocapsid Is Required for Human APOBEC3G Packaging. J. Virol. 78: 11841-11852 [Abstract] [Full Text]  
• Peters, P. J., Bhattacharya, J., Hibbitts, S., Dittmar, M. T., Simmons, G., Bell, J., Simmonds, P., Clapham, P. R. (2004). Biological Analysis of Human Immunodeficiency Virus Type 1 R5 Envelopes Amplified from Brain and Lymph Node Tissues of AIDS Patients with Neuropathology Reveals Two Distinct Tropism Phenotypes and Identifies Envelopes in the Brain That Confer an Enhanced Tropism and Fusigenicity for Macrophages. J. Virol. 78: 6915-6926 [Abstract] [Full Text]  
• Lundquist, C. A., Zhou, J., Aiken, C. (2004). Nef Stimulates Human Immunodeficiency Virus Type 1 Replication in Primary T Cells by Enhancing Virion-Associated gp120 Levels: Coreceptor-Dependent Requirement for Nef in Viral Replication. J. Virol. 78: 6287-6296 [Abstract] [Full Text]  
• Bhattacharya, J., Peters, P. J., Clapham, P. R. (2004). Human Immunodeficiency Virus Type 1 Envelope Glycoproteins That Lack Cytoplasmic Domain Cysteines: Impact on Association with Membrane Lipid Rafts and Incorporation onto Budding Virus Particles. J. Virol. 78: 5500-5506 [Abstract] [Full Text]  
• Stebbing, J., Gazzard, B., Douek, D. C. (2004). Where Does HIV Live?. NEJM 350: 1872-1880 [Full Text]  
• Bogerd, H. P., Doehle, B. P., Wiegand, H. L., Cullen, B. R. (2004). From The Cover: A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor. Proc. Natl. Acad. Sci. USA 101: 3770-3774 [Abstract] [Full Text]  
• Dooher, J. E., Lingappa, J. R. (2004). Conservation of a Stepwise, Energy-Sensitive Pathway Involving HP68 for Assembly of Primate Lentivirus Capsids in Cells. J. Virol. 78: 1645-1656 [Abstract] [Full Text]  
• Liu, B., Yu, X., Luo, K., Yu, Y., Yu, X.-F. (2004). Influence of Primate Lentiviral Vif and Proteasome Inhibitors on Human Immunodeficiency Virus Type 1 Virion Packaging of APOBEC3G. J. Virol. 78: 2072-2081 [Abstract] [Full Text]  
• Jensen, M. A., Li, F.-S., van 't Wout, A. B., Nickle, D. C., Shriner, D., He, H.-X., McLaughlin, S., Shankarappa, R., Margolick, J. B., Mullins, J. I. (2003). Improved Coreceptor Usage Prediction and Genotypic Monitoring of R5-to-X4 Transition by Motif Analysis of Human Immunodeficiency Virus Type 1 env V3 Loop Sequences. J. Virol. 77: 13376-13388 [Abstract] [Full Text]  
• Zhang, K., Rana, F., Silva, C., Ethier, J., Wehrly, K., Chesebro, B., Power, C. (2003). Human Immunodeficiency Virus Type 1 Envelope-Mediated Neuronal Death: Uncoupling of Viral Replication and Neurotoxicity. J. Virol. 77: 6899-6912 [Abstract] [Full Text]  
• Pincus, S. H., Fang, H., Wilkinson, R. A., Marcotte, T. K., Robinson, J. E., Olson, W. C. (2003). In Vivo Efficacy of Anti-Glycoprotein 41, But Not Anti-Glycoprotein 120, Immunotoxins in a Mouse Model of HIV Infection. J. Immunol. 170: 2236-2241 [Abstract] [Full Text]  
• Learn, G. H., Muthui, D., Brodie, S. J., Zhu, T., Diem, K., Mullins, J. I., Corey, L. (2002). Virus Population Homogenization following Acute Human Immunodeficiency Virus Type 1 Infection. J. Virol. 76: 11953-11959 [Abstract] [Full Text]  
• Cormier, E. G., Dragic, T. (2002). The Crown and Stem of the V3 Loop Play Distinct Roles in Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Interactions with the CCR5 Coreceptor. J. Virol. 76: 8953-8957 [Abstract] [Full Text]  
• Keppler, O. T., Welte, F. J., Ngo, T. A., Chin, P. S., Patton, K. S., Tsou, C.-L., Abbey, N. W., Sharkey, M. E., Grant, R. M., You, Y., Scarborough, J. D., Ellmeier, W., Littman, D. R., Stevenson, M., Charo, I. F., Herndier, B. G., Speck, R. F., Goldsmith, M. A. (2002). Progress Toward a Human CD4/CCR5 Transgenic Rat Model for De Novo Infection by Human Immunodeficiency Virus Type 1. J. Exp. Med. 195: 719-736 [Abstract] [Full Text]  
• Johnston, J. B., Silva, C., Power, C. (2002). Envelope Gene-Mediated Neurovirulence in Feline Immunodeficiency Virus Infection: Induction of Matrix Metalloproteinases and Neuronal Injury. J. Virol. 76: 2622-2633 [Abstract] [Full Text]  
• Keppler, O. T., Yonemoto, W., Welte, F. J., Patton, K. S., Iacovides, D., Atchison, R. E., Ngo, T., Hirschberg, D. L., Speck, R. F., Goldsmith, M. A. (2001). Susceptibility of Rat-Derived Cells to Replication by Human Immunodeficiency Virus Type 1. J. Virol. 75: 8063-8073 [Abstract] [Full Text]  
• Dragic, T. (2001). An overview of the determinants of CCR5 and CXCR4 co-receptor function. J. Gen. Virol. 82: 1807-1814 [Full Text]  
• Sova, P., Volsky, D. J., Wang, L., Chao, W. (2001). Vif Is Largely Absent from Human Immunodeficiency Virus Type 1 Mature Virions and Associates Mainly with Viral Particles Containing Unprocessed Gag. J. Virol. 75: 5504-5517 [Abstract] [Full Text]  
• Cormier, E. G., Tran, D. N. H., Yukhayeva, L., Olson, W. C., Dragic, T. (2001). Mapping the Determinants of the CCR5 Amino-Terminal Sulfopeptide Interaction with Soluble Human Immunodeficiency Virus Type 1 gp120-CD4 Complexes. J. Virol. 75: 5541-5549 [Abstract] [Full Text]  
• Scales, D., Ni, H., Shaheen, F., Capodici, J., Cannon, G., Weissman, D. (2001). Nonproliferating Bystander CD4+ T Cells Lacking Activation Markers Support HIV Replication During Immune Activation. J. Immunol. 166: 6437-6443 [Abstract] [Full Text]  
• Henzler, T., Harmache, A., Herrmann, H., Spring, H., Suzan, M., Audoly, G., Panek, T., Bosch, V. (2001). Fully functional, naturally occurring and C-terminally truncated variant human immunodeficiency virus (HIV) Vif does not bind to HIV Gag but influences intermediate filament structure. J. Gen. Virol. 82: 561-573 [Abstract] [Full Text]  
• Trouplin, V., Salvatori, F., Cappello, F., Obry, V., Brelot, A., Heveker, N., Alizon, M., Scarlatti, G., Clavel, F., Mammano, F. (2001). Determination of Coreceptor Usage of Human Immunodeficiency Virus Type 1 from Patient Plasma Samples by Using a Recombinant Phenotypic Assay. J. Virol. 75: 251-259 [Abstract] [Full Text]  
• Bieniasz, P. D., Cullen, B. R. (2000). Multiple Blocks to Human Immunodeficiency Virus Type 1 Replication in Rodent Cells. J. Virol. 74: 9868-9877 [Abstract] [Full Text]  
• Singh, A., Collman, R. G. (2000). Heterogeneous Spectrum of Coreceptor Usage among Variants within a Dualtropic Human Immunodeficiency Virus Type 1 Primary-Isolate Quasispecies. J. Virol. 74: 10229-10235 [Abstract] [Full Text]  
• Schramm, B., Penn, M. L., Palacios, E. H., Grant, R. M., Kirchhoff, F., Goldsmith, M. A. (2000). Cytopathicity of Human Immunodeficiency Virus Type 2 (HIV-2) in Human Lymphoid Tissue Is Coreceptor Dependent and Comparable to That of HIV-1. J. Virol. 74: 9594-9600 [Abstract] [Full Text]  
• Nelson, J. A. E., Baribaud, F., Edwards, T., Swanstrom, R. (2000). Patterns of Changes in Human Immunodeficiency Virus Type 1 V3 Sequence Populations Late in Infection. J. Virol. 74: 8494-8501 [Abstract] [Full Text]  
• Arthos, J., Rubbert, A., Rabin, R. L., Cicala, C., Machado, E., Wildt, K., Hanbach, M., Steenbeke, T. D., Swofford, R., Farber, J. M., Fauci, A. S. (2000). CCR5 Signal Transduction in Macrophages by Human Immunodeficiency Virus and Simian Immunodeficiency Virus Envelopes. J. Virol. 74: 6418-6424 [Abstract] [Full Text]  
• Etemad-Moghadam, B., Sun, Y., Nicholson, E. K., Fernandes, M., Liou, K., Gomila, R., Lee, J., Sodroski, J. (2000). Envelope Glycoprotein Determinants of Increased Fusogenicity in a Pathogenic Simian-Human Immunodeficiency Virus (SHIV-KB9) Passaged In Vivo. J. Virol. 74: 4433-4440 [Abstract] [Full Text]  
• Wodrich, H., Schambach, A., Krausslich, H.-G. (2000). Multiple copies of the Mason-Pfizer monkey virus constitutive RNA transport element lead to enhanced HIV-1 Gag expression in a context-dependent manner. Nucleic Acids Res 28: 901-910 [Abstract] [Full Text]  
• Maeda, Y., Foda, M., Matsushita, S., Harada, S. (2000). Involvement of both the V2 and V3 Regions of the CCR5-Tropic Human Immunodeficiency Virus Type 1 Envelope in Reduced Sensitivity to Macrophage Inflammatory Protein 1alpha. J. Virol. 74: 1787-1793 [Abstract] [Full Text]  
• Shiino, T., Kato, K., Kodaka, N., Miyakuni, T., Takebe, Y., Sato, H. (2000). A Group of V3 Sequences from Human Immunodeficiency Virus Type 1 Subtype E Non-Syncytium-Inducing, CCR5-Using Variants Are Resistant to Positive Selection Pressure. J. Virol. 74: 1069-1078 [Abstract] [Full Text]  
• Schramm, B., Penn, M. L., Speck, R. F., Chan, S. Y., De Clercq, E., Schols, D., Connor, R. I., Goldsmith, M. A. (2000). Viral Entry through CXCR4 Is a Pathogenic Factor and Therapeutic Target in Human Immunodeficiency Virus Type 1 Disease. J. Virol. 74: 184-192 [Abstract] [Full Text]  
• Li, S., Juarez, J., Alali, M., Dwyer, D., Collman, R., Cunningham, A., Naif, H. M. (1999). Persistent CCR5 Utilization and Enhanced Macrophage Tropism by Primary Blood Human Immunodeficiency Virus Type 1 Isolates from Advanced Stages of Disease and Comparison to Tissue-Derived Isolates. J. Virol. 73: 9741-9755 [Abstract] [Full Text]  
• Hung, C.-S., Vander Heyden, N., Ratner, L. (1999). Analysis of the Critical Domain in the V3 Loop of Human Immunodeficiency Virus Type 1 gp120 Involved in CCR5 Utilization. J. Virol. 73: 8216-8226 [Abstract] [Full Text]  
• Vahlenkamp, T. W., De Ronde, A., Schuurman, N. N. M. P., van Vliet, A. L. W., van Drunen, J., Horzinek, M. C., Egberink, H. F. (1999). Envelope gene sequences encoding variable regions 3 and 4 are involved in macrophage tropism of feline immunodeficiency virus. J. Gen. Virol. 80: 2639-2646 [Abstract] [Full Text]  
• Ping, L.-H., Nelson, J. A. E., Hoffman, I. F., Schock, J., Lamers, S. L., Goodman, M., Vernazza, P., Kazembe, P., Maida, M., Zimba, D., Goodenow, M. M., Eron, J. J. Jr., Fiscus, S. A., Cohen, M. S., Swanstrom, R. (1999). Characterization of V3 Sequence Heterogeneity in Subtype C Human Immunodeficiency Virus Type 1 Isolates from Malawi: Underrepresentation of X4 Variants. J. Virol. 73: 6271-6281 [Abstract] [Full Text]  
• Cartier, C., Sivard, P., Tranchat, C., Decimo, D., Desgranges, C., Boyer, V. (1999). Identification of Three Major Phosphorylation Sites within HIV-1 Capsid. ROLE OF PHOSPHORYLATION DURING THE EARLY STEPS OF INFECTION. J. Biol. Chem. 274: 19434-19440 [Abstract] [Full Text]  
• Kato, K., Sato, H., Takebe, Y. (1999). Role of Naturally Occurring Basic Amino Acid Substitutions in the Human Immunodeficiency Virus Type 1 Subtype E Envelope V3 Loop on Viral Coreceptor Usage and Cell Tropism. J. Virol. 73: 5520-5526 [Abstract] [Full Text]  
• Sato, H., Shiino, T., Kodaka, N., Taniguchi, K., Tomita, Y., Kato, K., Miyakuni, T., Takebe, Y. (1999). Evolution and Biological Characterization of Human Immunodeficiency Virus Type 1 Subtype E gp120 V3 Sequences following Horizontal and Vertical Virus Transmission in a Single Family. J. Virol. 73: 3551-3559 [Abstract] [Full Text]  
• Voulgaropoulou, F., Tan, B., Soares, M., Hahn, B., Ratner, L. (1999). Distinct Human Immunodeficiency Virus Strains in the Bone Marrow Are Associated with the Development of Thrombocytopenia. J. Virol. 73: 3497-3504 [Abstract] [Full Text]  
• Chan, S. Y., Speck, R. F., Power, C., Gaffen, S. L., Chesebro, B., Goldsmith, M. A. (1999). V3 Recombinants Indicate a Central Role for CCR5 as a Coreceptor in Tissue Infection by Human Immunodeficiency Virus Type 1. J. Virol. 73: 2350-2358 [Abstract] [Full Text]  
• Penn, M. L., Grivel, J.-C., Schramm, B., Goldsmith, M. A., Margolis, L. (1999). CXCR4 utilization is sufficient to trigger CD4+ T cell depletion in HIV-1-infected human lymphoid tissue. Proc. Natl. Acad. Sci. USA 96: 663-668 [Abstract] [Full Text]  
• Sakaida, H., Hori, T., Yonezawa, A., Sato, A., Isaka, Y., Yoshie, O., Hattori, T., Uchiyama, T. (1998). T-Tropic Human Immunodeficiency Virus Type 1 (HIV-1)-Derived V3 Loop Peptides Directly Bind to CXCR-4 and Inhibit T-Tropic HIV-1 Infection. J. Virol. 72: 9763-9770 [Abstract] [Full Text]  
• Power, C., McArthur, J. C., Nath, A., Wehrly, K., Mayne, M., Nishio, J., Langelier, T., Johnson, R. T., Chesebro, B. (1998). Neuronal Death Induced by Brain-Derived Human Immunodeficiency Virus Type 1 Envelope Genes Differs between Demented and Nondemented AIDS Patients. J. Virol. 72: 9045-9053 [Abstract] [Full Text]  
• Ostrowski, M. A., Krakauer, D. C., Li, Y., Justement, S. J., Learn, G., Ehler, L. A., Stanley, S. K., Nowak, M., Fauci, A. S. (1998). Effect of Immune Activation on the Dynamics of Human Immunodeficiency Virus Replication and on the Distribution of Viral Quasispecies. J. Virol. 72: 7772-7784 [Abstract] [Full Text]  
• Misse, D., Cerutti, M., Schmidt, I., Jansen, A., Devauchelle, G., Jansen, F., Veas, F. (1998). Dissociation of the CD4 and CXCR4 Binding Properties of Human Immunodeficiency Virus Type 1 gp120 by Deletion of the First Putative Alpha-Helical Conserved Structure. J. Virol. 72: 7280-7288 [Abstract] [Full Text]  
• Valli, P. J. S., Lukashov, V. V., Heeney, J. L., Goudsmit, J. (1998). Shortening of the Symptom-Free Period in Rhesus Macaques Is Associated with Decreasing Nonsynonymous Variation in the env Variable Regions of Simian Immunodeficiency Virus SIVsm during Passage. J. Virol. 72: 7494-7500 [Abstract] [Full Text]  
• Owen, S. M., Ellenberger, D., Rayfield, M., Wiktor, S., Michel, P., Grieco, M. H., Gao, F., Hahn, B. H., Lal, R. B. (1998). Genetically Divergent Strains of Human Immunodeficiency Virus Type 2 Use Multiple Coreceptors for Viral Entry. J. Virol. 72: 5425-5432 [Abstract] [Full Text]  
• Belec, L., Mohamed, A. S., Muller-Trutwin, M. C., Gilquin, J., Gutmann, L., Safar, M., Barre-Sinoussi, F., Kazatchkine, M. D. (1998). Genetically Related Human Immunodeficiency Virus Type 1 in Three Adults of a Family with No Identified Risk Factor for Intrafamilial Transmission. J. Virol. 72: 5831-5839 [Abstract] [Full Text]  
• Chen, S. S.-L., Lee, S.-F., Hao, H.-J., Chuang, C.-K. (1998). Mutations in the Leucine Zipper-Like Heptad Repeat Sequence of Human Immunodeficiency Virus Type 1 gp41 Dominantly Interfere with Wild-Type Virus Infectivity. J. Virol. 72: 4765-4774 [Abstract] [Full Text]  
• Spencer Valli, P. J., Goudsmit, J. (1998). Structured-Tree Topology and Adaptive Evolution of the Simian Immunodeficiency Virus SIVsm Envelope during Serial Passage in Rhesus Macaques According to Likelihood Mapping and Quartet Puzzling. J. Virol. 72: 3673-3683 [Abstract] [Full Text]  
• Platt, E. J., Wehrly, K., Kuhmann, S. E., Chesebro, B., Kabat, D. (1998). Effects of CCR5 and CD4 Cell Surface Concentrations on Infections by Macrophagetropic Isolates of Human Immunodeficiency Virus Type 1. J. Virol. 72: 2855-2864 [Abstract] [Full Text]  
• Wei, Q., Fultz, P. N. (1998). Extensive Diversification of Human Immunodeficiency Virus Type 1 Subtype B Strains during Dual Infection of a Chimpanzee That Progressed to AIDS. J. Virol. 72: 3005-3017 [Abstract] [Full Text]  
• Trkola, A., Ketas, T., KewalRamani, V. N., Endorf, F., Binley, J. M., Katinger, H., Robinson, J., Littman, D. R., Moore, J. P. (1998). Neutralization Sensitivity of Human Immunodeficiency Virus Type 1 Primary Isolates to Antibodies and CD4-Based Reagents Is Independent of Coreceptor Usage. J. Virol. 72: 1876-1885 [Abstract] [Full Text]  
• Patterson, S, English, N., Longhurst, H, Balfe, P, Helbert, M, Pinching, A., Knight, S. (1998). Analysis of human immunodeficiency virus type 1 (HIV-1) variants and levels of infection in dendritic and T cells from symptomatic HIV-1- infected patients. J. Gen. Virol. 79: 247-257 [Abstract]  
• Parolin, C., Borsetti, A., Choe, H., Farzan, M., Kolchinsky, P., Heesen, M., Ma, Q., Gerard, C., Palu, G., Dorf, M. E., Springer, T., Sodroski, J. (1998). Use of Murine CXCR-4 as a Second Receptor by Some T-Cell-Tropic Human Immunodeficiency Viruses. J. Virol. 72: 1652-1656 [Abstract] [Full Text]  
• Dumonceaux, J., Nisole, S., Chanel, C., Quivet, L., Amara, A., Briand, P., Hazan, U. (1998). Spontaneous Mutations in the env Gene of the Human Immunodeficiency Virus Type 1 NDK Isolate Are Associated with a CD4-Independent Entry Phenotype. J. Virol. 72: 512-519 [Abstract] [Full Text]  
• Esté, J. A., Schols, D., De Vreese, K., Van Laethem, K., Vandamme, A.-M., Desmyter, J., De Clercq, E. (1997). Development of Resistance of Human Immunodeficiency Virus Type 1 to Dextran Sulfate Associated with the Emergence of Specific Mutations in the Envelope gp120 Glycoprotein. Mol. Pharmacol. 52: 98-104 [Abstract] [Full Text]  
• Brown, A. J. L. (1997). Analysis of HIV-1 env gene sequences reveals evidence for a low effective number in the viral population. Proc. Natl. Acad. Sci. USA 94: 1862-1865 [Abstract] [Full Text]  
• Yamaguchi, Y., Gojobori, T. (1997). Evolutionary mechanisms and population dynamics of the third variable envelope region of HIV within single hosts. Proc. Natl. Acad. Sci. USA 94: 1264-1269 [Abstract] [Full Text]  
• Jansson, M., Popovic, M., Karlsson, A., Cocchi, F., Rossi, P., Albert, J., Wigzell, H. (1996). Sensitivity to inhibition by beta -chemokines correlates with biological phenotypes of primary HIV-1 isolates. Proc. Natl. Acad. Sci. USA 93: 15382-15387 [Abstract] [Full Text]  
• Catasti, P., Bradbury, E. M., Gupta, G. (1996). Structure and Polymorphism of HIV-1 Third Variable Loops. J. Biol. Chem. 271: 8236-8242 [Abstract] [Full Text]  
• Catasti, P., Fontenot, J. D., Bradbury, E. M., Gupta, G. (1995). Local and Global Structural Properties of the HIV-MN V3 Loop. J. Biol. Chem. 270: 2224-2232 [Abstract] [Full Text]  
• Callebaut, C, Krust, B, Jacotot, E, Hovanessian, A. (1993). T cell activation antigen, CD26, as a cofactor for entry of HIV in CD4+ cells. Science 262: 2045-2050 [Abstract]  
• Zhu, T, Mo, H, Wang, N, Nam, D., Cao, Y, Koup, R., Ho, D. (1993). Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science 261: 1179-1181 [Abstract]